[go: up one dir, main page]

SE9000625D0 - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE9000625D0
SE9000625D0 SE9000625A SE9000625A SE9000625D0 SE 9000625 D0 SE9000625 D0 SE 9000625D0 SE 9000625 A SE9000625 A SE 9000625A SE 9000625 A SE9000625 A SE 9000625A SE 9000625 D0 SE9000625 D0 SE 9000625D0
Authority
SE
Sweden
Prior art keywords
filling
matrix
pharmaceutical compositions
paraffin
dissolution
Prior art date
Application number
SE9000625A
Other languages
English (en)
Other versions
SE9000625L (sv
SE512412C2 (sv
Inventor
S K Chopra
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of SE9000625D0 publication Critical patent/SE9000625D0/sv
Publication of SE9000625L publication Critical patent/SE9000625L/sv
Publication of SE512412C2 publication Critical patent/SE512412C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9000625A 1989-02-23 1990-02-22 Farmaceutisk komposition i kapselform bestående av ranitidin och en icke-vattenhaltig grundmassa SE512412C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE9000625D0 true SE9000625D0 (sv) 1990-02-22
SE9000625L SE9000625L (sv) 1990-08-24
SE512412C2 SE512412C2 (sv) 2000-03-13

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000625A SE512412C2 (sv) 1989-02-23 1990-02-22 Farmaceutisk komposition i kapselform bestående av ranitidin och en icke-vattenhaltig grundmassa

Country Status (26)

Country Link
US (1) US5028432A (sv)
JP (1) JP2856817B2 (sv)
KR (1) KR940006271B1 (sv)
AT (1) AT401727B (sv)
AU (1) AU629303B2 (sv)
BE (1) BE1003123A3 (sv)
CA (1) CA2010692C (sv)
CH (1) CH680567A5 (sv)
CY (1) CY1734A (sv)
DE (1) DE4005650C2 (sv)
DK (1) DK170209B1 (sv)
FR (1) FR2643263B1 (sv)
GB (2) GB8904182D0 (sv)
HK (1) HK89493A (sv)
HU (1) HU211930A9 (sv)
IE (1) IE63179B1 (sv)
IL (1) IL93490A (sv)
IT (1) IT1240768B (sv)
LU (1) LU87681A1 (sv)
NL (1) NL193267C (sv)
NZ (1) NZ232642A (sv)
PH (1) PH26972A (sv)
SA (1) SA90100287B1 (sv)
SE (1) SE512412C2 (sv)
ZA (1) ZA901348B (sv)
ZW (1) ZW1790A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0548238A1 (en) * 1990-09-13 1993-06-30 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
ATE157867T1 (de) * 1992-10-16 1997-09-15 Glaxo Group Ltd Geschmacksmaskierende zusammensetzungen von ranitidin
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
JP2006518380A (ja) * 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
US7635675B2 (en) 2003-08-13 2009-12-22 Biocon Limited Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US9579269B2 (en) 2010-06-23 2017-02-28 Colgate-Palmolive Company Therapeutic oral composition
BR112013015571A8 (pt) 2010-12-20 2017-03-28 Colgate Palmolive Co Composição para cuidado oral encapsulada de gelatina contendo ativos de oclusão dentária, modificador de viscosidade hidrofóbico e carreador oleoso
JP2013545800A (ja) 2010-12-20 2013-12-26 コルゲート・パーモリブ・カンパニー 親水性活性剤、疎水性構造化剤および油担体を含有するゼラチンカプセル化された口腔ケア組成物
JP5752802B2 (ja) 2010-12-20 2015-07-22 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ デンタル閉塞活性物質を含有する非水性オーラルケア組成物
WO2018083583A1 (en) * 2016-11-01 2018-05-11 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
EP3846852A4 (en) * 2018-09-07 2022-06-15 R.P. Scherer Technologies, LLC Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
BE896711A (fr) * 1982-05-14 1983-09-01 Richter Gedeon Vegyeszet Compositions pharmaceutiques anti-ulceres.
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
AU556989B2 (en) * 1983-08-01 1986-11-27 R.P. Scherer Corporation Sustained release method and product
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
CA1327748C (en) * 1988-09-20 1994-03-15 Christopher William Quirk Pharmaceutical composition containing ranitidine and alginic acid

Also Published As

Publication number Publication date
NL193267B (nl) 1999-01-04
GB2229094A (en) 1990-09-19
PH26972A (en) 1992-12-28
IT9047659A1 (it) 1991-08-22
KR940006271B1 (ko) 1994-07-14
HU211930A9 (en) 1996-01-29
IE900651L (en) 1990-08-23
AU629303B2 (en) 1992-10-01
SA90100287B1 (ar) 1999-08-15
DK48090D0 (da) 1990-02-22
NZ232642A (en) 1992-07-28
NL193267C (nl) 1999-05-06
KR900012612A (ko) 1990-09-01
BE1003123A3 (fr) 1991-12-03
HK89493A (en) 1993-09-03
ATA42190A (de) 1996-04-15
CA2010692C (en) 1995-12-12
SE9000625L (sv) 1990-08-24
JP2856817B2 (ja) 1999-02-10
CY1734A (en) 1994-05-06
DE4005650C2 (de) 1999-03-25
DK170209B1 (da) 1995-06-19
LU87681A1 (fr) 1991-10-08
ZW1790A1 (en) 1991-10-16
SE512412C2 (sv) 2000-03-13
GB8904182D0 (en) 1989-04-05
NL9000428A (nl) 1990-09-17
IL93490A0 (en) 1990-11-29
ZA901348B (en) 1991-03-27
GB2229094B (en) 1993-01-06
AT401727B (de) 1996-11-25
IT9047659A0 (it) 1990-02-22
CH680567A5 (sv) 1992-09-30
AU5007390A (en) 1990-08-30
FR2643263A1 (fr) 1990-08-24
CA2010692A1 (en) 1990-08-23
DE4005650A1 (de) 1990-09-06
FR2643263B1 (fr) 1994-09-16
IT1240768B (it) 1993-12-17
GB9004016D0 (en) 1990-04-18
US5028432A (en) 1991-07-02
JPH03200728A (ja) 1991-09-02
DK48090A (da) 1990-08-24
IE63179B1 (en) 1995-03-22
IL93490A (en) 1994-07-31

Similar Documents

Publication Publication Date Title
SE9000625L (sv) Farmaceutiska kompositioner
US20030104048A1 (en) Pharmaceutical dosage forms for highly hydrophilic materials
KR910000655B1 (ko) 신규 형태의 연질캡슐 제조방법
KR900007397A (ko) 서방성 제제
DE59008336D1 (de) Orale Lipidarzneiform.
DE3171928D1 (en) Pharmaceutical formulation and its preparation
KR940021054A (ko) 캡슐형 유비데카레논 경구 제제
US4339463A (en) Enterosoluble hard-capsulated medicaments
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
KR890011594A (ko) 4-아로일이미다졸-2-온의 제약 조성물
KR930005635A (ko) 약제학적 조성물
US5482973A (en) Suppository preparation
JPH10330250A (ja) メナテトレノン油性製剤
JPS60218318A (ja) 軟カプセル充填用組成物
EP0046036B1 (en) Compositions containing povidone-iodine
JPS6277320A (ja) Ｌ−アスコルビン酸製剤およびその製造法
KR950016750A (ko) 신규의 장용성 오메프라졸 연질캅셀 및 그 제조방법
JPS61200909A (ja) 経口投与持続性カプセル剤
JPS57149219A (en) Hard capsule preparation containing tocopherol nicotinate in high concentration
KR900000073A (ko) 제약적으로 유효한 물질의 경구투여용 액체복용 형태
KR920019344A (ko) α-리놀렌산을 이용한 간장질환의 예방 및 치료 조성물